AKT2 and lung cancer: Sung et al. examined six SNPs in the promoter regions of AKT2 and AKT3 in 360 lung cancer patients and 360 normal controls and found that the variant genotypes and haplotypes were not significantly associated with risk of lung cancer in a Korean population20.